Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy
Neurological Sciences · 2025-03 · 46 (3) · 1323-1327
DOI: 10.1007/s10072-024-07860-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neurological Sciences, online erschienen am 05.11.2024. Verfasst von Fahang Yi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Encephalitis, Viral, Herpesvirus 6, Human, Roseolovirus Infections, Immunotherapy, Adoptive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Human herpesvirus (HHV)-6 encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapyis relatively rare in clinical practice and needs to be differentiated from immune effector cell-associatedneurotoxicity syndrome (ICANS). METHODS: We retrospectively reported a case of HHV-6 encephalitis secondary to CAR-T cell therapy. RESULTS: A male patient from China with diffuse large B-cell lymphoma underwent chimeric CAR-T cell therapy anddeveloped a generalized rash on the 8th day, followed by cognitive changes, memory loss, and disorientation onthe 14th day after CAR-T cell therapy. Initially, ICANS was suspected. A lumbar puncture was performed on the 18th day. The cerebrospinal fluid (CSF) analysis revealed slightly elevated protein levels and a high presence of HHV-6B sequences by mNGS. Brain MRI showed bilateral hippocampal abnormalities. The patient was ultimatelydiagnosed with HHV-6 encephalitis and treated with ganciclovir and dexamethasone. After one week of treatment,follow-up CSF analysis showed a reduction in HHV-6B sequences. The patient was discharged with improvedmemory and orientation. CONCLUSION: HHV-6 encephalitis secondary to CAR-T cell therapy may be easily confused with ICANS. Timely andaggressive diagnostic procedures, such as mNGS of CSF and cranial imaging, along with prompt antiviral therapy,are crucial for improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. wang0128_0@163.com.
Zitieren
APA
Yi, F., Qin, N., & Wang, L. (2025). Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy. Neurological Sciences, 46(3), 1323-1327. https://doi.org/10.1007/s10072-024-07860-7
Vancouver
Yi F, Qin N, Wang L. Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy. Neurological Sciences. 2025;46(3):1323-1327. doi:10.1007/s10072-024-07860-7
BibTeX
@article{Yi2025,
author = {Yi, Fahang and Qin, Ningxiang and Wang, Liang},
title = {Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy},
journal = {Neurological Sciences},
year = {2025},
volume = {46},
number = {3},
pages = {1323--1327},
doi = {10.1007/s10072-024-07860-7}
}
EUVIMED